glp-1 news november 3 2025 ISPOR 2025: Exploring reasons for GLP-1 discontinuation Mapping the effectiveness and risks

Herrington WG, Staplin N, Wanner C et al

CLICK HERE TO GET THE FOX NEWS APP Nausea and blood sugar changes were similar between groups, suggesting that the "less buzzed" effect wasnt due to feeling sick

But it represents the most significant government intervention in GLP-1 access to date, and it provides a template for how structured programs might bridge the gap between clinical need and financial reality

Discuss Alternatives If the transition back to the commercial product is going to be financially challenging for your patient, discuss alternatives

After propensity matching for age, sex, race, and obesity, 69,221 patients were included in the primary analysis

Requests must arrive at least 72 hours before the billing date